Astellas Pharma Inc. total revenue, net income and dynamics of changes in US dollar today
Astellas Pharma Inc. revenue for the past few reporting periods. The dynamics of Astellas Pharma Inc. net revenue increased by 21 729 000 000 $ from the last reporting period. These are the main financial indicators of Astellas Pharma Inc.. Astellas Pharma Inc. online financial report chart. Astellas Pharma Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Astellas Pharma Inc. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019
2 184 883 755.52 $
-5.55 % ↓
397 430 203.25 $
-29.857 % ↓
30/09/2019
2 044 451 178.58 $
-0.527 % ↓
452 461 884.08 $
+41.99 % ↑
30/06/2019
2 159 478 055.31 $
+1.53 % ↑
378 196 582.33 $
+7.26 % ↑
31/03/2019
1 947 404 118.18 $
-
198 605 232.15 $
-
31/12/2018
2 313 282 393.57 $
-
566 596 879.19 $
-
30/09/2018
2 055 276 553.26 $
-
318 666 715.97 $
-
30/06/2018
2 126 846 821.43 $
-
352 609 920.63 $
-
Show:
to
Astellas Pharma Inc. financial report charts
The latest dates of Astellas Pharma Inc. financial statements available online: 30/06/2018, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Astellas Pharma Inc. is 31/12/2019. Gross profit Astellas Pharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Astellas Pharma Inc. is 255 295 000 000 $
Astellas Pharma Inc. quarterly report dates
Cost of revenue Astellas Pharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Astellas Pharma Inc. is 82 770 000 000 $ Total revenue Astellas Pharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Astellas Pharma Inc. is 338 065 000 000 $ Operating revenue Astellas Pharma Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Astellas Pharma Inc. is 338 065 000 000 $
Operating income Astellas Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Astellas Pharma Inc. is 76 154 000 000 $ Net income Astellas Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Astellas Pharma Inc. is 61 494 000 000 $ Current assets Astellas Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Astellas Pharma Inc. is 834 150 000 000 $
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 649 948 673.67 $
1 602 646 633.51 $
1 703 765 327.37 $
1 531 586 935.25 $
1 769 292 774.45 $
1 584 750 835.02 $
1 669 686 401.59 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
534 935 081.85 $
441 804 545.06 $
455 712 727.93 $
415 817 182.93 $
543 989 619.11 $
470 525 718.24 $
457 160 419.83 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 184 883 755.52 $
2 044 451 178.58 $
2 159 478 055.31 $
1 947 404 118.18 $
2 313 282 393.57 $
2 055 276 553.26 $
2 126 846 821.43 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
2 184 883 755.52 $
2 044 451 178.58 $
2 159 478 055.31 $
1 947 404 118.18 $
2 313 282 393.57 $
2 055 276 553.26 $
2 126 846 821.43 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
492 176 467.60 $
554 440 145 $
502 911 361.53 $
464 961 152.51 $
536 615 438.51 $
411 318 997.39 $
412 340 137.21 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
397 430 203.25 $
452 461 884.08 $
378 196 582.33 $
198 605 232.15 $
566 596 879.19 $
318 666 715.97 $
352 609 920.63 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
354 038 223.80 $
332 626 602.12 $
345 810 939.04 $
379 521 478.93 $
325 685 436.50 $
306 555 222.15 $
336 924 437.44 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
1 692 707 287.92 $
1 490 011 033.58 $
1 656 566 693.78 $
1 482 442 965.67 $
1 776 666 955.05 $
1 643 957 555.87 $
1 714 506 684.22 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
5 391 036 589.61 $
5 529 640 162.95 $
5 300 426 587.83 $
5 539 741 691.68 $
5 753 657 558.23 $
5 464 481 101.75 $
5 459 440 031.76 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
12 859 763 105.25 $
12 795 373 130.37 $
12 454 228 412.53 $
12 264 328 720.50 $
12 462 591 418.41 $
12 195 033 396.74 $
12 063 351 600.28 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 794 116 812.74 $
2 012 336 977.52 $
1 676 621 104.30 $
2 010 443 344.81 $
2 141 136 316 $
1 983 253 881.37 $
2 001 828 285.44 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
3 012 091 027.85 $
3 125 631 435.22 $
2 999 837 350.01 $
3 204 045 925.35 $
3 196 503 709.08 $
2 892 669 372.15 $
2 834 936 194.84 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
4 345 227 840.80 $
4 418 568 946.38 $
4 377 477 762.97 $
4 131 428 306.64 $
4 111 160 620.08 $
3 905 155 355.68 $
3 817 188 684.20 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
33.79 %
34.53 %
35.15 %
33.69 %
32.99 %
32.02 %
31.64 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
8 514 535 264.45 $
8 376 804 183.99 $
8 076 750 649.56 $
8 132 900 413.86 $
8 351 430 798.33 $
8 289 878 041.05 $
8 246 162 916.09 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
443 555 993.74 $
609 109 902.85 $
47 903 090.81 $
355 130 455.63 $
591 970 264.85 $
484 117 218.51 $
240 284 540.39 $
Last revenue report of Astellas Pharma Inc. was 31/12/2019. According to last financial report total revenue in Astellas Pharma Inc. was 2 184 883 755.52 US dollar and changed by -5.55% since last year. Net income in Astellas Pharma Inc. was 397 430 203.25 $ in last quartal, net income changes to -29.857%.
Total assets Astellas Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Astellas Pharma Inc. is 1 989 779 000 000 $ Current cash Astellas Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Astellas Pharma Inc. is 277 602 000 000 $ Current debt Astellas Pharma Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Astellas Pharma Inc. is 466 058 000 000 $
Astellas Pharma Inc. stocks data
ALPMF stock price
Astellas Pharma Inc. stock price today, ALPMF stock quote.
